OralDosed ingredient Cosmetic cross-reference

Barium Sulfate

CAS 7727-43-7

Barium Sulfate (CAS 7727-43-7) is a Phase 4 pharmaceutical compound with 0 bioactivity targets and 49 adverse event associations.

SOURCE NLM DailyMed

Label records

SOURCE EMBL-EBI ChEMBL

Bioactivity

SOURCE DrugCentral

Adverse signals

SOURCE IUPHAR/BPS

PubMed IDs

SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name

Barium Sulfate

CAS Number

7727-43-7

UNII

25BB7EKE2E

InChIKey

TZCXTZWJZNENPQ-UHFFFAOYSA-L

ChEMBL ID

CHEMBL2105897

Molecule Type

Small molecule

Source Match

EMBL-EBI ChEMBL (INCHIKEY)

dosed ingredientoral

SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Clinical Development Phase

Highest clinical development phase rendered from the matched compound identifier rows.

Phase 4 (Approved)

Approved or marketed human pharmaceutical use is represented in the source phase field.

ChEMBL CHEMBL2105897 | Small molecule

SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

This substance also has a cosmetic safety profile →

SOURCE DrugCentral 6 associations

Adverse Event Associations

DrugCentral / FAERS disproportionality signal rows matched to this compound.

Reaction PT	Drug AE	LLR	MedDRA
Aspiration	74	391.124	10003504
No adverse event	54	201.751	10067482
Expired product administered	15	66.786	10074902
Urticaria	26	50.656	10046735
Product physical consistency issue	8	45.372	10073760
Product colour issue	8	45.121	10069221

Association rows are source-linked signal records, not incidence rates or clinical causality claims.

SOURCE NLM RxNorm 3 name rows

Drug Names / RxNorm

Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.

Name	RxCUI	Type	Source
BARIUM SULFATE	1331	SU	MTHSPL
Barium Sulfate	1331	SU	MTHSPL
barium sulfate	1331	IN	RXNORM

SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is Barium Sulfate used for in pharmaceutical contexts?

Barium Sulfate (CAS 7727-43-7) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for Barium Sulfate?

Barium Sulfate has 49 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Aspiration, No adverse event, Expired product administered, Urticaria, Product physical consistency issue. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is Barium Sulfate also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for Barium Sulfate with EU status "permitted".

What clinical phase is Barium Sulfate in?

Barium Sulfate is rendered with ChEMBL max phase 4 (approved).